Neurogene (NGNE) Intangibles (2019 - 2022)
Neurogene's (NGNE) quarterly Intangibles came in at $18000.0 in Q2 2022, down 92.44% YoY from $238000.0 in Q2 2021, and down 75.34% on a QoQ basis from $73000.0 in Q1 2022.
Analysis
Neurogene (NGNE) Intangibles (2019 - 2022) Analysis & Trends
Neurogene (NGNE) has 4 years of Intangibles data on file, last reported at $18000.0 in Q2 2022.
- Quarterly Intangibles fell 92.44% year-over-year to $18000.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $18000.0 (down 92.44% YoY) and the FY2021 annual result came in at $128000.0, down 63.11% from the prior year.
- Intangibles retreated to $18000.0 in Q2 2022, from $73000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $622000.0 in Q3 2019 to a low of $18000.0 in Q2 2022.
- A 4-year average of $320250.0 and a median of $320000.0 in 2020 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2020 — Intangibles tumbled 35.21% — and 2022, when it sank 92.44%.
- Tracing NGNE's Intangibles over 4 years: stood at $567000.0 in 2019, then sank by 38.8% to $347000.0 in 2020, then tumbled by 63.11% to $128000.0 in 2021, then slumped by 85.94% to $18000.0 in 2022.
- The last three Intangibles figures came in at $18000.0 (Q2 2022), $73000.0 (Q1 2022), and $128000.0 (Q4 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 63.28 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 60.96 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Neurogene | 864.53 Mn | 864.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 18,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 128,000.00 |
| Sep 30, 2021 | 183,000.00 |
| Jun 30, 2021 | 238,000.00 |
| Mar 31, 2021 | 293,000.00 |
| Dec 31, 2020 | 347,000.00 |
| Sep 30, 2020 | 403,000.00 |
| Jun 30, 2020 | 458,000.00 |
| Mar 31, 2020 | 513,000.00 |
| Dec 31, 2019 | 567,000.00 |
| Sep 30, 2019 | 622,000.00 |